April 16-18, 2024
Javits Center, NYC

INTERPHEX 2020 Exhibitor Award Winners Announced

Recognizing Innovation that Delivers Improved Outcome and Acceleration to Market and Return on Investment

NEW YORK, NY; July 15, 2020 – INTERPHEX, International Pharmaceutical Expo (INTERPHEX), the premier Event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, and INTERPHEX Exhibitor Awards sponsor American Pharmaceutical Review, the leading review of business and technology for the pharmaceutical industry throughout North America, and Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services, today announced the winners of the 2020 INTERPHEX Exhibitor Awards. The next edition of INTERPHEX takes place April 20-22, 2021 at the Javits Center in New York, New York.

“The INTERPHEX Exhibitor Awards represent the future of pharmaceutical, biotech and device development and manufacturing innovation. Each year, we are delighted to recognize state-of-the-art technologies, products and services which reduce cost, increase productivity and maximize efficiency”, said Kate Scott, Event Director, INTERPHEX. “A special thank you to head judge, Mike Auerbach, Editor-in-Chief, American Pharmaceutical Review and Pharmaceutical Outsourcing, for submissions review and overall support of the awards program. Congratulations to this year’s winners!”

Best in Show: MilliporeSigma - The BioContinuum™ Buffer Delivery Platform
The BioContinuum™ Buffer Delivery Platform integrates buffer concentrates, buffer dilution system, Mobius® Select assemblies and services providing the ideal path to intensify buffer preparation and management with simplicity and certainty. The Platform delivers a competitive edge by supplying process buffers from point of manufacturing to point of use utilizing a fraction of the resources and facility space while increasing speed and flexibility. The combination of buffer concentrates, Mobius® Select single-use, highly accurate and precise buffer dilution system and tailored services enables biomanufacturers to eliminate buffer preparation and management bottlenecks while reducing cleanroom floor space and capital expenditures, while adding preparation flexibility. In totality, the simplicity and certainty of the Platform enables the evolution of bioprocessing.

About the Award: The Best in Show Award recognizes accomplishments and display in the use of knowledge, innovation, and state-of-the-art technologies to achieve extraordinary levels of quality, production goals, and objectives—ultimately transforming critical and affordable life-enhancing ideas to finished drug products.

Best New Product/Service: Malvern Panalytical - Amplify Analytics
This collaboration binds together Concept Life Sciences’ expertise in discovery chemistry, API screening and GMP manufacturing with Malvern Panalytical’s extensive capabilities for detailed solid and morphological form analysis. The Amplify Analytics service improves outcomes by directly linking API selection to both ADMET and microstructural assessments, ensuring developable candidates are rapidly and accurately identified. In addition, the Amplify Analytics team can directly deploy the physicochemical characterization techniques and methods required to ensure process and quality control, thus supporting scale-up and manufacturing programs. This is a unique partnership which integrates API selection, manufacturing and characterization, accelerating product development to deliver improved development outcomes and a much faster return on investment.

About the Award: The Best New Product/Service Award is given to the exhibitor that encourages, develops, and features the very best in new products or services showcasing knowledge, innovation, and state-of-the-art technologies leading to significant business, economic, or manufacturing benefits for the pharma and bio industries.

Editor’s Choice (sponsored by Pharmaceutical Outsourcing): MilliporeSigma-The BioReliance® Blazar™ Platform
The BioReliance® Blazar™ Platform meets the need to accelerate detection of adventitious viral contamination. This rapid molecular platform/degenerate PCR approach detects panel specific targeted viruses and related, but unknown viral contaminants and benefits the industry in several ways. It accelerates the broad and sensitive detection of adventitious viruses by replacing biological growth-based systems with a molecular approach. It provides manufacturers with accurate and highly sensitive viral detection in just days. Combining the breadth of detection of NGS with the speed and sensitivity of PCR. The Blazar™ Platform relies on degenerate PCR primers enabling coverage of beyond 5000 viral variants and will drive transformation of biosafety testing, particularly since the current method was developed in 1964. The Blazar™ platform enables biopharma to bring therapies to market faster.

About the Award: The Editor of Pharmaceutical Processing awards the Editor’s Choice Award, which is based upon her view of the best in exhibiting in Knowledge, Innovation, and Technologies within the pharma and biopharma industries.

Best Technologies Innovation: Fluid Air - PolarDry Electrostatic Systems
PolarDry Electrostatic Systems were designed around a complete line of patent-pending machines enabling easy scale-up from R&D through production size models. The systems utilize electrostatic technology which drives water to the shell and active to the core, lowering the evaporation temperature and eliminating active ingredient loss, degradation, or denaturalization. Harnessing the electrostatic effect, the dispersed active driven into the core is microencapsulated, virtually eliminating surface active, resulting in stunning encapsulation efficiency. PolarDry Electrostatic Systems offer a revolutionary way to process powder ingredients, at lower temperatures, to produce a better-quality drug, with a longer shelf life.

About the Award: The Best Technologies Innovation Award recognizes cutting-edge technologies, either new technologies or a novel implementation of existing technologies that have the potential to change the way pharma/bio companies operate.

Efficiency Champion: SUEZ - Sievers TOC Analyzers and Sievers Eclipse Bacterial Endotoxins Testing (BET) Platform
The new Sievers Eclipse BET Platform, along with Sievers TOC Analyzers, increase efficiency of quality control testing of water and other applications within the pharmaceutical, biopharmaceutical, and medical device markets. The new BET platform automates endotoxin assay setup through precise microfluidic liquid handling and embedded endotoxin standards. It maintains full compliance with the harmonized pharmacopoeias with embedded standards derived from the reference standard endotoxin produced by the USP along with FDA licensed limulus amoebocyte lysate. The Eclipse enhances the product development lifecycle by simplifying an otherwise antiquated and cumbersome benchtop assay and decreasing demand on natural resources. Using the Eclipse, manufacturers can gain operational efficiency by reducing pipetting steps by up to 89%, reducing analyst time by up to 85% and reducing the use of horseshoe crab lysate by up to 90%. The Eclipse enables fully compliant, 21-sample assay setup in as little as 9 minutes. Together, the new Sievers Eclipse BET platform and time-tested Sievers TOC Analyzers, part of SUEZ – Water Technologies & Solutions, increase productivity and ensure compliance.

About the Award: The INTERPHEX Efficiency Champion Award is given to an exhibitor whose product or service understands the need for integrated efficiencies in processes and supports the fast pace of the pharma/bio industry—whether in research, development, or commercial-scale production.

Biotech Innovation: Meissner Filtration Products - AccuFlux® Integrity Test Instrument
The AccuFlux® tests and delivers industry standard filter integrity test results (i.e. bubble point, diffusive flow, pressure hold, water intrusion) for critical applications in a fraction of the time that currently available integrity test instruments require, thus saving valuable operator and manufacturing time. The AccuFlux® can test filter integrity pre- and post-use to guarantee sterility for qualified release of final product to market. With the AccuFlux®, for example, a bubble point or diffusive flow test can be performed in 3 minutes or less. That reduces the time required by an operator to perform this test by 70%, which streamlines efficiencies and reduces total cost of labor.

About the Award: The Biotech Innovation Award acknowledges an exhibitor’s innovative application to a given product or service that not only addresses an industry need but does so in such a way as to exceed previous standards or applications—thereby making the given process simpler, smoother, or easier to navigate.

About American Pharmaceutical Review
American Pharmaceutical Review is the leading review journal for business and technology in the pharmaceutical industry throughout North America. Each issue offers 30,000 readers unbiased editorial coverage of the latest developments in: drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. With its in-depth coverage, American Pharmaceutical Review is able to keep its readership of senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing. American Pharmaceutical Review is published bi-monthly in January/February, March, April, May/June, July/August, September/October and November/December. Each issue reaches over 30,000 key decision makers for the pharmaceutical industry in North America. For questions or for advertising information on American Pharmaceutical Review please contact

About Pharmaceutical Outsourcing
Pharmaceutical Outsourcing is the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmaceutical Outsourcing is published quarterly with a Company Focus issue published in October. Each issue reaches over 20,000 key decision makers involved in outsourcing and contract services for the pharmaceutical and biopharmaceutical industries in North America. For questions or for advertising information on Pharmaceutical Outsourcing please contact

For forty-one years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization”. Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 11,000 global industry professionals and 625+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of exhibits, demonstrations, partnering opportunities, networking and no cost technical conference to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. INTERPHEX and INNOPHEX together, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. Follow INTERPHEX on FacebookLinkedInInstagramYouTube, and TwitterIPX Blog continues the learning beyond the show floor. For more information, visit